Enhabit Inc

Enhabit, Inc. functions as an investment holding company. It provides home health and hospice services. Its Home Health services give patients access to the care they deserve in the comfort of their own homes. From disease and injury management to recovery from surgery, clinicians help patients confidently achieve their healthcare goals. The firm's Hospice services place importance on the comfort of every patient living with a terminal illness. The company was founded in 2014 and is headquartered in Dallas, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Enhabit Inc reports solid Q4 performance amidst strategic changes

Enhabit Inc showcased solid financial performance in Q4 2022, with notable strengths in strategic changes and operational effectiveness.
Challenges include revenue impact from payer shifts and cost pressures, while opportunities lie in revenue growth and optimizing operational efficiency.
The company's focus on acquisitions, patient care optimization, and disciplined growth strategies will be key for future success.
Enhabit's performance, strengths, challenges, and opportunities position it for continued growth and operational excellence in the Home Health and Hospice sectors.

Enhabit Inc reports mixed Q1 results, focuses on growth opportunities

Enhabit Inc saw mixed performance with revenue decline but strong EBITDA guidance.
Challenges include lower patient days in hospice and rising G&A costs.
Opportunities lie in expanding patient accessibility and driving incremental volume.
Overall, Enhabit is focused on independent operation amidst industry consolidation.

Enhabit Inc reports strong growth amidst Medicare Advantage challenges

Enhabit Inc showcased strong performance in non-episodic admissions and cash flow generation, while facing challenges from Medicare Advantage shifts.
The company's strengths lie in recruitment efforts, successful negotiations, and strategic focus on hospice management.
Challenges include maintaining relationships amidst market shifts and diversifying patient mix in hospice.
Opportunities exist in addressing challenges through recruitment strategies, strategic alternatives, and adapting to market changes.

Enhabit reports Q3 revenue decline but secures covenant relief

Enhabit Inc's Q3 2023 performance reflected revenue and EBITDA declines, but strategic initiatives and financial management strength support future growth prospects.
The company's recognition for workplace culture and operational focus are key strengths, while challenges in admissions and financial metrics require targeted solutions.
Opportunities in Medicare pricing, volume growth, and hospice segment trends offer avenues for Enhabit to drive revenue and operational improvements in the coming quarters.

Enhabit Inc reports Q4 results, eyes growth through strategic initiatives

Enhabit Inc's Q4 2023 performance showed mixed results with revenue decline but growth in key segments, setting the stage for strategic initiatives in 2024.
The company's focus on payer innovation contracts, Medicare Advantage transitions, and hospice case management highlights a path for future growth and operational excellence.
While facing challenges in contract predictability and regulatory uncertainties, Enhabit's strengths in contract quality and operational performance present opportunities for sustained success.
Enhabit's financial outlook for 2024 includes a focus on revenue growth, cost management, and strategic expansion, positioning the company for continued progress and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

Enhabit, Inc. (NYSE:EHAB ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Jobie Williams – Senior Vice President and Treasurer Barb Jacobsmeyer – President and Chief Executive Officer Crissy Carlisle – Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies A. J. Rice – UBS Ryan Langston – TD Cowen Operator Good morning, everyone and welcome to Enhabit's Home Health and Hospice's Third Quarter, 2024 Earnings Conference Call.

Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Transcript

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. M.

Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

Enhabit (EHAB) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.

Enhabit (EHAB) Misses Q3 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. “Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction,” said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. “The payor innovation strategy continues to fo.

Enhabit Reports Third Quarter 2024 Financial Results

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant. Age-friendly Health Systems Participants are recognized for being on the journey to becoming an Age-Friendly Health System and have submitted a description of how they are putting four essential elements of care--the 4Ms--into practice with older patients. "We're participa.

Enhabit Home Health & Hospice Recognized as an Age-Friendly Health Systems Participant

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Inte.

Enhabit Home Health & Hospice Announces Date of 2024 Third Quarter Earnings Call

On September 30, 2024, Vanguard Group Inc, a prominent investment firm, executed a significant transaction involving the shares of Enhabit Inc (EHAB, Financial). The firm reduced its holdings by 626,911 shares, which adjusted its total stake in the company to 2,976,480 shares.

Vanguard Group Inc's Strategic Reduction in Enhabit Inc Shares

Adient

Bio-Rad Laboratories

Community Healthcare Trust

Compass Minerals

CNH Industrial NV

Designer Brands

3D Systems

Dell Technologies

Dine Brands Global

Fabrinet

Haverty Furniture Companies

Inspire Medical Systems Inc

MP Materials

Nu Skin Enterprises

Palantir Technologies

Parsons Corp

S&P Global

TEGNA

Western Alliance Bancorporation

Wolfspeed

Clear Secure

Zurn Water Solutions Corp

NEW YORK , Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance.

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in the following events: Jefferies Healthcare Services “Back to School” Summit and Bus Tour When: Aug. 28 Venue: 1 Hotel Nashville in Nashville, Tenn. 2024 Wells Fargo Healthcare Conference When: Investor.

Enhabit Announces Participation in Upcoming Investor Conferences

Enhabit, Inc. (NYSE:EHAB ) Q2 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President & CEO Crissy Carlisle - CFO Conference Call Participants Noah Erni - Jefferies Ben Rossi - Citi A.J. Rice - UBS Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's second quarter 2024 earnings conference call.

Enhabit, Inc. (EHAB) Q2 2024 Earnings Call Transcript

Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago.

Enhabit (EHAB) Q2 Earnings Surpass Estimates

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. “Crissy has made important contributions to Enhabit since we became a public.

Enhabit Announces CFO Transition

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. “The second quarter marked our third sequential quarter demonstrating the success of our strategies,” said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. “In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved util.

Enhabit Reports Second Quarter 2024 Financial Results

Enhabit (EHAB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Here Is Why Bargain Hunters Would Love Fast-paced Mover Enhabit (EHAB)

Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Enhabit (EHAB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Enhabit (EHAB) Reports Next Week: Wall Street Expects Earnings Growth

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today commented on the outcome of Enhabit's 2024 Annual Meeting of Stockholders (the “Annual Meeting”), in which stockholders elected Mark W. Ohlendorf to the Company's board of directors (the “Board”). AREX Managing Partner, Andrew Rechtschaffen, and Partner, James T.

AREX Capital Announces Director Appointment to Enhabit Board

Advantage Solutions

Credit Acceptance

Frontdoor Inc.

V.F.

Advantage Solutions currently trades at an attractive upside-to-downside ratio. Credit Acceptance's management allocates free cash flow to growing the business and repurchasing shares at attractive prices. Enhabit has historically earned high returns on capital and grew both organically and through acquisitions.

Curreen Capital's Top 5% Positions: Where I Am Finding The Most Value

Solventum Corporation

We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through resolvable issues, and selling at attractive prices. I love buying businesses like this, and if it drops to my next buy price, we will add to it.

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (the “Company”), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit's director nominees at the 2024 Annual Meeting of Stockholders: Jeffrey W. Bolton Tina L. Brown-Stevenson Charles M. Elson Erin P. Hoeflinger Barbara A. Jacobsmeyer Stuart M. McGuigan Gregory S. Rush Barry P. Schochet Additionally, the preliminar.

Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders

Enhabit (EHAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Enhabit (EHAB) is Poised to Beat Earnings Estimates Again

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit's current board of directors by electing the full AREX slate, which AREX believes will support the creation of long-term value for all stockholders. The full text.

AREX Capital Urges Fellow Stockholders to Support Meaningful Change at Enhabit at the Upcoming Annual Meeting

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today reminded stockholders to protect the value of their investment by voting ahead of the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) which will be held on July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the Annual Meeting. With this year's Annual Meeting just days away, stockholders are bei.

Enhabit Urges Stockholders to Protect the Value of their Investment by Voting FOR Enhabit's Nominees at the July 25 Annual Meeting

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today announced that Glass, Lewis & Co. (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that Enhabit's stockholders support significant boardroom change by voting for three of its director candidates at the Company's 2024 Annual Meeting.

Glass Lewis Recommends Stockholders Support Significant Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital's Nominees

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0.

News for Enhabit Inc Stock (EHAB)